$80.21▴ 4.86%
End-of-day close · 2026-08-06
What most investors miss
Trends, drivers and alerts — the full picture.
Profit → Cash
$0.96cash per $1 profit
Healthy
Most of its reported profit shows up as real cash.
Valuation
13th pctvs its own history
Cheap
Its valuation sits in the cheaper end of its own recent range.
Revenue growth
+20.7%year over year
Strong
Revenue is growing strongly year over year.
Leverage
Not enough data yet
Term-debt data is not available for this company.
More coming: dilution / share-count creep.
Fair value
Undervalued
Trading about 19% below our fair-value range
A cash-flow (DCF) estimate cross-checked against peer multiples.
✦ The read
TransMedics Group, Inc. turns 96¢ of every reported profit-dollar into real cash. Most of its reported profit shows up as real cash. Revenue is growing strongly year over year. Its valuation sits in the cheaper end of its own recent range.
Key numbers
Valuation
EPS (TTM)$3.86
TTM (trailing 12 months, through fiscal Q2 FY2026)
Profitability
Net margin22.7%
TTM (trailing 12 months, through fiscal Q2 FY2026)
Size
Revenue (TTM)$668.47M
TTM (trailing 12 months, through fiscal Q2 FY2026)
Recent news
Sentiment · last 30 days2 articles
2 bullish0 neutral0 bearish
Why TransMedics Stock Is Sinking TodayAtlas Healthcare Fund by VST Capital Entered Eli Lilly at $350 in 2020 — The Stock Now Trades Above $1,200
Where Will TransMedics Group Stock Be in 10 Years?
3 Growth Stocks to Buy on the Dip
What a $722,000 TransMedics Insider Sale Might Mean After a 45% Stock Drop
Signals and key numbers are from the fiscal Q2 FY2026 filing. Price freshness: end-of-day close on Free, 15-min delayed on Pro.